Cargando…
Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma
Pediatric sarcomas, including rhabdomyosarcomas, Ewing’s sarcoma, and osteosarcoma, are aggressive tumors with poor survival rates. To overcome problems associated with nonselectivity of the current therapeutic approaches, targeted therapeutics have been developed. Currently, an increasing number of...
Autores principales: | Nordberg, Janne, Mpindi, John Patrick, Iljin, Kristiina, Pulliainen, Arto Tapio, Kallajoki, Markku, Kallioniemi, Olli, Elenius, Klaus, Elenius, Varpu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515522/ https://www.ncbi.nlm.nih.gov/pubmed/23227212 http://dx.doi.org/10.1371/journal.pone.0050819 |
Ejemplares similares
-
Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor
por: Määttä, Jorma A, et al.
Publicado: (2009) -
Cell Death or Survival Promoted by Alternative Isoforms of ErbB4
por: Sundvall, Maria, et al.
Publicado: (2010) -
ErbB4 tyrosine kinase inhibition impairs neuromuscular development in zebrafish embryos
por: Paatero, Ilkka, et al.
Publicado: (2019) -
Proteolytic Processing of ErbB4 in Breast Cancer
por: Hollmén, Maija, et al.
Publicado: (2012) -
Genome-wide screen of gamma-secretase–mediated intramembrane cleavage of receptor tyrosine kinases
por: Merilahti, Johannes A. M., et al.
Publicado: (2017)